Skip to main content

Table 2 Multiple logistic regression regarding different psychotropic drug use

From: Psychotropic drug use among people with dementia – a six-month follow-up study

  Odds ratio 95% confidence interval p-value
Antidepressants (N06A)    
Male sex 0.727 0.381-1.385 0.332
Higher age 0.932 0.897-0.969 0.000
Moderate cognitive impairmenta 1.971 1.072-3.622 0.029
Mild cognitive impairmenta 0.933 0.460-1.894 0.848
Anxiolytics (N05B)    
Male sex 0.522 0.181-1.505 0.229
Higher age 0.985 0.939-1.032 0.521
Moderate cognitive impairmenta 0.606 0.242-1.514 0.283
Mild cognitive impairmenta 1.331 0.509-3.481 0.560
Verbally disruptive/attention- 2.193 1.389-3.462 0.001
seeking behavior    
Hypnotics and sedatives (N05C)    
Male sex 1.769 0.917-3.413 0.089
Higher age 0.932 0.896-0.971 0.001
Moderate cognitive impairmenta 1.401 0.725-2.705 0.316
Mild cognitive impairmenta 3.627 1.685-7.810 0.001
Disoriented symptoms 1.545 1.169-2.041 0.002
  1. Model Cox and Snell R2: 0.078, concordance between observed and predicted value: 65.4% (antidepressants): 0.070/85.5% (anxiolytics): 0.138/69.9% (hypnotics and sedatives). aCognitive score ranges from 0–27 points and a score of less than 24 is considered to indicate cognitive impairment. The scale is subdivided into three groups, 0–7 (severe cognitive impairment), 8–15 (moderate cognitive impairment) and 16–23 (mild cognitive impairment). Severe cognitive impairment is reference category.